Insider Buy/Sell Details for the Healthcare Sector — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2297)
NEUROCRINE BIOSCIENCES INC (NBIX)
Lippoldt Darin — Chief Legal Officer
Shares
200
Price
$169.56
Total Value
$33.91K
Shares Held After
54,729
% of Holdings
0.4%
LifeStance Health Group, Inc. (LFST)
Bessler Robert — Director
Shares
447,169
Price
$10.13
Total Value
$4.53M
Shares Held After
656,560
% of Holdings
40.5%
LifeStance Health Group, Inc. (LFST)
Bessler Robert — Director
Shares
447,168
Price
$10.13
Total Value
$4.53M
Shares Held After
539,763
% of Holdings
45.3%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
596
Price
$482.50
Total Value
$287.57K
Shares Held After
15,337
% of Holdings
3.7%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
2,500
Price
$44.90
Total Value
$112.25K
Shares Held After
886
% of Holdings
73.8%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
232
Price
$44.90
Total Value
$10.42K
Shares Held After
886
% of Holdings
20.8%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Vericel Corp (VCEL)
Hopper Jonathan Mark — Chief Medical Officer
Shares
5,000
Price
$45.00
Total Value
$225.00K
Shares Held After
75,753
% of Holdings
6.2%
Vericel Corp (VCEL)
Flynn Sean C. — Chief Legal Officer
Shares
15,000
Price
$45.64
Total Value
$684.60K
Shares Held After
1,647
% of Holdings
90.1%
Vericel Corp (VCEL)
Mara Joseph Anthony Jr — Chief Financial Officer
Shares
5,000
Price
$44.75
Total Value
$223.75K
Shares Held After
16,009
% of Holdings
23.8%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
17,196
Price
$25.18
Total Value
$433.00K
Shares Held After
211,462
% of Holdings
7.5%
Privia Health Group, Inc. (PRVA)
Morris Matthew Shawn — Director
Shares
88,110
Price
$25.33
Total Value
$2.23M
Shares Held After
76,651
% of Holdings
53.5%
Ceribell, Inc. (CBLL)
TPG GP A, LLC — Former 10% Owner
Shares
202,368
Price
$20.12
Total Value
$4.07M
Shares Held After
3,765,054
% of Holdings
5.1%
Fulcrum Therapeutics, Inc. (FULC)
Ezekowitz Alan — Director
Shares
18,000
Price
$3.65
Total Value
$65.61K
Shares Held After
10,927
% of Holdings
62.2%
ProQR Therapeutics N.V. (PRQR)
Filius Bart — Director
Shares
150,000
Price
$1.54
Total Value
$231.00K
Shares Held After
150,000
% of Holdings
100.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
134
Price
$2.54
Total Value
$340.36
Shares Held After
2,469,083
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
75,047
Price
$2.55
Total Value
$191.37K
Shares Held After
2,468,949
% of Holdings
3.0%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
500,000
Price
$34.08
Total Value
$17.04M
Shares Held After
18,677,617
% of Holdings
2.6%
Pharvaris N.V. (PHVS)
Lu Peng — Chief Medical Officer
Shares
14,700
Price
$34.00
Total Value
$499.85K
Shares Held After
65,631
% of Holdings
18.3%
ACADIA PHARMACEUTICALS INC (ACAD)
Kihara James — PRINCIPAL ACCOUNTING OFFICER
Shares
11,421
Price
$26.08
Total Value
$297.91K
Shares Held After
13,088
% of Holdings
46.6%
Canopy Growth Corp (CGC)
Yanofsky Theresa — Director
Shares
15,054
Price
$0.92
Total Value
$13.91K
Shares Held After
146,415
% of Holdings
9.3%
Zai Lab Ltd (ZLAB)
Edmondson Frazor Titus III — Chief Legal Officer
Shares
4,103
Price
$17.46
Total Value
$71.64K
Shares Held After
30,346
% of Holdings
11.9%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
24,543
Price
$17.46
Total Value
$428.55K
Shares Held After
1,192,840
% of Holdings
2.0%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
31,940
Price
$5.84
Total Value
$186.40K
Shares Held After
3,601,493
% of Holdings
0.9%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
18,129
Price
$5.73
Total Value
$103.93K
Shares Held After
3,601,493
% of Holdings
0.5%
Canopy Growth Corp (CGC)
Lazzarato David Angelo — Director
Shares
22,674
Price
$0.92
Total Value
$20.94K
Shares Held After
211,859
% of Holdings
9.7%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
1,876
Price
$8.98
Total Value
$16.85K
Shares Held After
16,795,919
% of Holdings
0.0%
Zai Lab Ltd (ZLAB)
Chen Yajing — Chief Financial Officer
Shares
2,264
Price
$17.46
Total Value
$39.53K
Shares Held After
35,691
% of Holdings
6.0%
Canopy Growth Corp (CGC)
BAYERN JOSEPH — Director
Shares
3,197
Price
$0.92
Total Value
$2.95K
Shares Held After
145,127
% of Holdings
2.2%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
149,795
Price
$29.79
Total Value
$4.46M
Shares Held After
8,990,566
% of Holdings
1.6%
Oscar Health, Inc. (OSCR)
Bertolini Mark T — Director
Shares
441,373
Price
$29.11
Total Value
$12.85M
Shares Held After
9,140,361
% of Holdings
4.6%
Canopy Growth Corp (CGC)
ATKINS M SHAN — Director
Shares
3,197
Price
$0.92
Total Value
$2.95K
Shares Held After
146,517
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$553.49
Total Value
$22.14K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$552.36
Total Value
$154.66K
Shares Held After
40,553
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$550.79
Total Value
$220.32K
Shares Held After
40,833
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$549.69
Total Value
$285.84K
Shares Held After
41,233
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
872
Price
$548.90
Total Value
$478.64K
Shares Held After
41,753
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
452
Price
$548.13
Total Value
$247.75K
Shares Held After
42,625
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
156
Price
$547.00
Total Value
$85.33K
Shares Held After
43,077
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$545.52
Total Value
$305.49K
Shares Held After
43,233
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
439
Price
$544.18
Total Value
$238.89K
Shares Held After
43,793
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,012
Price
$543.32
Total Value
$549.84K
Shares Held After
44,232
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
983
Price
$542.14
Total Value
$532.93K
Shares Held After
45,244
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,128
Price
$541.24
Total Value
$1.15M
Shares Held After
46,227
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,018
Price
$539.89
Total Value
$549.61K
Shares Held After
48,355
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$538.34
Total Value
$344.54K
Shares Held After
49,373
% of Holdings
1.3%
Phio Pharmaceuticals Corp. (PHIO)
Bitterman Robert J — Director
Shares
10,000
Price
$0.99
Total Value
$9.90K
Shares Held After
421,421
% of Holdings
2.4%
Beam Therapeutics Inc. (BEAM)
FMR LLC — 10% Owner
Shares
251,488
Price
$35.26
Total Value
$8.87M
Shares Held After
854,583
% of Holdings
22.7%
BECTON DICKINSON & CO (BDX)
Feld Michael — EVP, Chief Revenue Officer
Shares
75
Price
$152.80
Total Value
$11.46K
Shares Held After
21,009
% of Holdings
0.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
9,029
Price
$3.05
Total Value
$27.54K
Shares Held After
105,989
% of Holdings
7.9%
Showing 251–300 of 2297 transactions (page 6 of 46)